Reported 2 days ago
Merck & Co., Inc. (NYSE:MRK) is highlighted as one of the best high dividend stocks under $100, boasting a strong track record of increasing dividends over 16 years. While its heavy reliance on the cancer drug Keytruda raises concerns about future revenue after existing patents expire, the company's robust research and development and capability to acquire smaller firms support its long-term stability. Currently, MRK offers a quarterly dividend of $0.81 per share, equating to a dividend yield of 3.97%.
Source: YAHOO